NASDAQ:ACOR - Acorda Therapeutics, Inc.
$6.58
 $-0.32
-4.64%
4:00PM EDT
2019-07-22
Acorda Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. As of December 31, 2016, the Company marketed three United States Food and Drug Administration (FDA)-approved therapies, including Ampyra (dalfampridine) Extended Release Tablets, 10 milligram (mg), a treatment to improve walking in patients with multiple sclerosis (MS). The Company also markets Zanaflex Capsules and tablets, FDA-approved as short-acting drugs for the management of spasticity, and Qutenza, an FDA-approved dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia, also known as post-shingles pain. The Company has a pipeline of neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and MS. The Company's product candidate, CVT-301, is a self-administered inhaled formulation of levodopa. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ACOR     avg for
industry  
  avg for
sector  
42 stocks weight:  28. 36   0. 00   0. 00  
42 stocks rank:  2. 98 K 1. 35 K 799. 74  
# analyst opinions:  9. 00   12. 76   13. 14  
mean recommendation:  2. 90   2. 11   2. 07  

quick ratio:  3. 74   5. 61   1. 85  
current ratio:  4. 30   6. 00   2. 31  

target price low:  8. 00   75. 88   108. 31  
target price avg:  9. 87   97. 27   130. 10  
target price high:  17. 11   124. 58   149. 02  
1-yr high:  29. 20   104. 89   135. 09  
last close:  6. 58   79. 79   118. 76  
50-day avg:  8. 37   79. 39   116. 18  
200-day avg:  13. 85   81. 61   114. 52  
1-yr low:  6. 56   62. 76   94. 70  
volume:  501. 85 K 2. 99 M 4. 43 M
50-day avg volume:  866. 80 K 3. 39 M 4. 22 M
200-day avg volume:  864. 33 K 3. 13 M 4. 83 M

1-day return:  -4. 64 % 0. 33 % 0. 14 %
this week return:  -4. 64 % 0. 33 % 0. 14 %
12-wk return:  -43. 95 % 1. 00 % 3. 51 %
52-wk return:  -75. 44 % 0. 58 % 10. 25 %

enterprise value (EV):  368. 58 M 44. 78 B 115. 63 B
market cap:  287. 98 M 38. 01 B 103. 29 B
EBITDA:  65. 17 M 4. 47 B 7. 73 B
enterprise multiple (EV/EBITDA):  5. 66   2. 11   11. 26  
enterprise/revenue (EV/R):  0. 90   61. 53   10. 40  
total revenue:  409. 40 M 10. 43 B 31. 15 B
total debt:  380. 37 M 11. 72 B 16. 76 B
debt/equity:  67. 13   61. 22   124. 43  
net income (common):  -5. 72 M 2. 06 B 3. 79 B

shares outstanding:  48. 13 M 562. 08 M 1. 27 B
shares:  38. 86 M 573. 33 M 1. 26 B
shares short:  13. 48 M 11. 60 M 12. 29 M
shares short prior month:  12. 57 M 9. 81 M 12. 46 M
short ratio:  12. 99   5. 88   3. 41  
short % of float:  49. 05 % 6. 88 % 2. 72 %
total cash/share:  7. 14   10. 62   8. 83  
total cash:  343. 25 M 6. 17 B 5. 72 B
free cash flow:  6. 39 M 3. 08 B 3. 10 B
operating cash flow:  44. 60 M 3. 99 B 4. 08 B

book value:  11. 94   12. 74   26. 25  
price/book:  0. 55   4. 38   9. 01  
gross profits:  372. 12 M 7. 93 B 35. 64 B
operating margins:  12. 74 % -319. 65 % -29. 05 %
EBITDA margins:  15. 92 % 11. 82 % 24. 13 %
profit margins:  -1. 40 % 5. 62 % 14. 29 %
gross margins:  78. 63 % 34. 75 % 57. 07 %

1-yr max volatility:  24. 19 % --- ---
1-yr mean volatility:  2. 88 % 1. 95 % 1. 25 %

1-yr EPS:  -0. 12   1. 58   3. 82  
forward EPS:  -3. 05   3. 16   6. 65  
P/E:  -54. 38   0. 21   31. 97  
forward P/E:  -2. 26   4. 95   15. 14  
PE/G:  0. 93   0. 74   0. 13  
growth:  -58. 40 % 295. 81 % 85. 47 %
earnings high:  -0. 96   0. 84   1. 56  
earnings avg:  -1. 06   0. 65   1. 45  
earnings low:  -1. 15   0. 40   1. 35  
revenue high:  39. 67 M 2. 70 B 8. 76 B
revenue avg:  28. 82 M 2. 64 B 8. 62 B
revenue low:  7. 80 M 2. 58 B 8. 45 B
return on assets:  2. 69 % -3. 43 % 4. 51 %
return on equity:  -1. 02 % -104. 30 % 140. 44 %
revenue growth:  -58. 40 % 295. 25 % 78. 55 %
revenue/share:  8. 66   12. 50   51. 58  

beta (1yr vs S&P500):  1. 42   1. 27   0. 91  
sharpe (1yr):  -1. 99   0. 20   0. 80  

held % insiders:  1. 85 % 6. 63 % 3. 46 %
held % institutions:  112. 32 % 76. 45 % 67. 87 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-22 : ACOR
.    105.969 =       105.969 :: --> INITIAL WEIGHT <--
.    - 0.121 =       105.848 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 5.636 =       596.528 :: P/E factor
.    x 1.018 =       607.259 :: PE/G factor
.    x 1.568 =       951.889 :: beta factor
.    x 0.729 =       693.683 :: sharpe factor
.    x 2.716 =      1883.858 :: current ratio factor
.    x 1.168 =      2200.943 :: quick ratio factor
.    x 1.038 =      2284.089 :: short ratio factor
.    x 1.046 =      2389.175 :: return on assets factor
.    x 1.015 =      2424.121 :: EV/R factor
.    x 1.003 =      2430.794 :: price-to-book factor
.    x 3.089 =      7509.268 :: EBITDA factor
.    x 1.294 =      9719.378 :: EBITDA vs industry factor
.    x 1.076 =     10461.293 :: debt-to-revenue factor
.     x 1.38 =      14432.92 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.759 =     39823.815 :: sector+industry 1-year gains factor
.     x 1.01 =     40221.458 :: industry 12-weeks return factor
.    x 1.309 =     52664.629 :: industry 2-weeks return factor
.    x 0.992 =     52223.357 :: "drift" penalty 1 days ago
.    x 0.974 =     50855.137 :: "drift" penalty 5 days ago
.    / 1.993 =     25521.719 :: overall "drift" factor
.     x 0.88 =     22456.073 :: largest single-day jump factor
.    x 0.094 =      2118.497 :: low price factor
.    x 1.059 =       2244.07 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.701 =      1573.544 :: forward EPS factor
.    x 0.891 =      1402.692 :: forward P/E factor
.    x 1.184 =      1660.732 :: industry recommendation factor
.    x 1.642 =      2726.496 :: company recommendation factor
.    x 1.002 =      2730.638 :: factor historical industry gain for week 29
.    x 1.576 =      4304.507 :: target low factor
.    x 1.236 =      5318.719 :: target mean factor
.    x 1.053 =       5601.31 :: target high factor
.    x 5.131 =     28737.701 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         13.02 :: reduced for readability
.   + 15.338 =        28.358 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     28.358 :: FINAL WEIGHT for NASDAQ:ACOR


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org